About Varka
Varka is a venture capital firm founded in 2017. It is primarily based out of Southport, United States. It primarily invests in United Kingdom based startups. Its investments are spread across Life Sciences sector.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Portfolio Soonicorns
Varka's List of All Investments
Varka has a portfolio of 2 companies. Their most notable investments are in Cycle Pharma and WaveBreak.Their portfolio spans across and United Kingdom. They have invested in Life Sciences. Here is the list of all investments by Varka:1. Cycle Pharma
Cycle Pharma is a UK-based biopharma that works on small molecule drug reformulation and repurposing for orphan indications. In Aug.2017, they received FDA approval for their lead candidate, NITYR (nitisinone tablets), indicated for the rare genetic disease, Hereditary Tyrosinemia type 1 (HT-1). The formulation does not require refrigeration and can be dissolved in water for pediatric patients. The company also manufactures generics.
Key facts about Cycle Pharma
- Founded Year: 2012
- Location: Cambridge (United Kingdom)
- Annual Revenue: £100M - £500M as on Dec 31, 2024
- Stage: Funding Raised
- Employee Count: 232 as on Jul 31, 2026
- Investors: Deutsche Bank, Varka and 31 Others
- Latest Funding Round: Conventional Debt, Sep 07, 2020, $*****
2. WaveBreak
Developer of small molecule therapeutics for neurological disorders. It offers drugs that targets the fleeting protein intermediates, the oligomers to treat Parkinson’s disease, Alzheimer’s disease, and ALS.
Key facts about WaveBreak
- Founded Year: 2016
- Location: Cambridge (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $64.3M
- Employee Count: 7 as on Jul 31, 2026
- Investors: The Baupost Group, University of Cambridge and 10 Others
- Latest Funding Round: Series A, Apr 02, 2024, $*****
- Highlight: Editors' Pick
